Literature DB >> 20885005

Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells.

Catrin Wernicke1, Julian Hellmann, Ulrich Finckh, Hans Rommelspacher.   

Abstract

There is evidence for ethanol-induced impairment of the dopaminergic system in the brain during development. The dopamine D2 receptor (DRD2) and the dopamine transporter (DAT) are decisively involved in dopaminergic signaling. Two splice variants of DRD2 are known, with the short one (DRD2s) representing the autoreceptor and the long one (DRD2l) the postsynaptic receptor. We searched for a model to investigate the impact of chronic ethanol exposure and withdrawal on the expression of these proteins during neuronal differentiation. RA-induced differentiation of human neuroblastoma SH-SY5Y cells seems to represent such a model. Our real-time RT-PCR, Western blot, and immunocytochemistry analyses of undifferentiated and RA-differentiated cells have demonstrated the enhanced expression of both splice variants of DRD2, with the short one being stronger enhanced than the long one under RA-treatment, and the DRD2 distribution on cell bodies and neurites under both conditions. In contrast, DAT was down-regulated by RA. The DAT is functional both in undifferentiated and RA-differentiated cells as demonstrated by [(3)H]dopamine uptake. Chronic ethanol exposure during differentiation for up to 4 weeks resulted in a delayed up-regulation of DRD2s. Ethanol withdrawal caused an increased expression of DRD2l and a normalization of DRD2s. Thus the DRD2s/DRD2l ratio was still disturbed. The dopamine level was increased by RA-differentiation compared to controls and was diminished under RA/ethanol treatment and ethanol withdrawal compared to RA-only treated cells. In conclusion, chronic ethanol exposure impairs differentiation-dependent adaptation of dopaminergic proteins, specifically of DRD2s. RA-differentiating SH-SY5Y cells are suited to study the impact of chronic ethanol exposure and withdrawal on expression of dopaminergic proteins during neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20885005     DOI: 10.1016/s1734-1140(10)70322-4

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

1.  Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8.

Authors:  Santanu Adhikary; Sulagna Sanyal; Moitri Basu; Isha Sengupta; Sabyasachi Sen; Dushyant Kumar Srivastava; Siddhartha Roy; Chandrima Das
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

Review 2.  Genetic studies of alcohol dependence in the context of the addiction cycle.

Authors:  Matthew T Reilly; Antonio Noronha; David Goldman; George F Koob
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

3.  Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells.

Authors:  Julian Hellmann-Regen; Karen Gertz; Ria Uhlemann; Michael Colla; Matthias Endres; Golo Kronenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-21       Impact factor: 5.270

4.  Effects of selection for ethanol preference on gene expression in the nucleus accumbens of HS-CC mice.

Authors:  A M Colville; O D Iancu; D L Oberbeck; P Darakjian; C L Zheng; N A R Walter; C A Harrington; R P Searles; S McWeeney; R J Hitzemann
Journal:  Genes Brain Behav       Date:  2017-02-09       Impact factor: 3.449

5.  Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells.

Authors:  Matthew Dodson; Qiuli Liang; Michelle S Johnson; Matthew Redmann; Naomi Fineberg; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Autophagy       Date:  2013-12       Impact factor: 16.016

6.  Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

Authors:  Samantha Giordano; Jisun Lee; Victor M Darley-Usmar; Jianhua Zhang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines.

Authors:  A Chhibber; C E French; S W Yee; E R Gamazon; E Theusch; X Qin; A Webb; A C Papp; A Wang; C Q Simmons; A Konkashbaev; A S Chaudhry; K Mitchel; D Stryke; T E Ferrin; S T Weiss; D L Kroetz; W Sadee; D A Nickerson; R M Krauss; A L George; E G Schuetz; M W Medina; N J Cox; S E Scherer; K M Giacomini; S E Brenner
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

8.  Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.

Authors:  Alessandro Tozzi; Michela Tantucci; Saverio Marchi; Petra Mazzocchetti; Michele Morari; Paolo Pinton; Andrea Mancini; Paolo Calabresi
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

9.  Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium.

Authors:  Stephanie C Gantz; Brooks G Robinson; David C Buck; James R Bunzow; Rachael L Neve; John T Williams; Kim A Neve
Journal:  Elife       Date:  2015-08-26       Impact factor: 8.140

10.  Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence.

Authors:  N Fernàndez-Castillo; J Cabana-Domínguez; J Soriano; C Sànchez-Mora; C Roncero; L Grau-López; E Ros-Cucurull; C Daigre; M M J van Donkelaar; B Franke; M Casas; M Ribasés; B Cormand
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.